Correlation of thyroid hormones with exocrine and endocrine pancreatic function in cystic fibrosis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00039470

Enrollment

186

Registered

2026-03-02

Start date

2026-01-07

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E84

Interventions

Group 1: Retrospective analysis of available thyroid values for Heidelberg CF patients from 1998 to 2025 with regard to the endocrine and exocrine pancreatic function of the patients and the clinical

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were in treatment between 1998 and 2025 and participate in the registry study “Establishment of a biobank and DNA bank with registry for patients with cystic fibrosis” (S-370/2011)

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
The neonatal TSH levels of all CF patients participating in our registry study between 1998 and 2025 will be evaluated as endpoints. This will be followed by a comparison of neonatal TSH levels between pancreas-sufficient and pancreas-deficient patients, as well as those who experienced a secondary rebound in fecal pancreatic elastase levels and those who did not.	—

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026